Company intelligence
Harrow
Ophthalmic-Focused Healthcare Company
About Harrow
Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market. Our mission as a growing leader in the ophthalmic healthcare market is driven by two core values: (1) unyielding dedication to innovation and (2) a mission of providing affordable and accessible medications. We pride ourselves on closely listening to the needs of providers and their patients, so we can do everything in our power to address them with high-quality products and services. In addition, our mission is producing amazing financial results, making Harrow one of the fastest-growing ophthalmic pharmaceutical companies in the United States.
Verified activity
Signals from Harrow
2 published signals
Presence & Recognition
Harrow is hosting the PrioritEYES VEVYE® 0.1% Challenge for eye care teams.
Reported by Veronica Balius
Products & Services
Harrow re-launched VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% last week to address vernal keratoconjunctivitis underdiagnosis and undertreatment.
Reported by Harrow